INmune Bio’s XPro1595 Prevents Brain-Injury-Induced Alzheimer's Pathology, Memory Loss, and Pain in New Peer-Reviewed Preclinical Study
Go back to INmune Bio’s XPro1595 Prevents Brain-Injury-Induced Alzheimer's Pathology, Memory Loss, and Pain in New Peer-Reviewed Preclinical Study| (NASDAQ: INMB) | Delayed: 2.54 +0.03 (1.20%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.51 | 52 Week High | $ | |||
| Open | $2.55 | 52 Week Low | $ | |||
| Day High | $2.58 | P/E | N/A | |||
| Day Low | $2.47 | EPS | $ | |||
| Volume | 134,197 | |||||
| (NASDAQ: INMB) | Delayed: 2.54 +0.03 (1.20%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.51 | 52 Week High | $ | |||
| Open | $2.55 | 52 Week Low | $ | |||
| Day High | $2.58 | P/E | N/A | |||
| Day Low | $2.47 | EPS | $ | |||
| Volume | 134,197 | |||||

